← Open Payments lookup

KARINA TREVINO: Open Payments

NPI 1760718811 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,167 in 90 payments from 25 companies in 2025. Trend: 2023 $1,575 · 2024 $1,621 · 2025 $2,167

Food & beverage: $2,167
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$358
Novo Nordisk Inc17$354
Dexcom, Inc.8$304
ABBVIE INC.14$182
Lilly USA, LLC8$179
Otsuka America Pharmaceutical, Inc.4$105
PFIZER INC.5$101
Verona Pharma, Inc.4$99
Merck Sharp & Dohme LLC4$88
GlaxoSmithKline, LLC.4$69

Products named: Dexcom G6 Transmitter, AIRSUPRA, BREZTRI, Ozempic, REXULTI, ELIQUIS, Ohtuvayre, VERQUVO.

Industry payments across TX — which companies pay providers there.